Yesterday, IPCPR and Cigar Rights of America filed a joint comment in response to the U.S. Food and Drug Administration’s ongoing review of how it should define and treat premium cigars. This process, known as an Advanced Notice of Proposed Rulemaking – marked a major milestone for premium cigar retailers, manufacturers, consumers and the
Category Archives: FDA
Federal Judge Delays Cigar Warning Requirements Earlier today, D.C. District Court Judge Amit Mehta issued an injunction prohibiting the U.S. Food & Drug Administration from enforcing its warning label requirements on cigars and pipe tobacco. The warning label requirements for packaging and advertising were slated to go into effect on August 10th. Judge Mehta’s order
Earlier this week, Senators Marco Rubio and Bill Nelson led a bipartisan letter to FDA Commissioner Scott Gottlieb, directing the FDA to bring quick regulatory relief to the premium cigar industry. Signed by 17 Senators, the letter outlines the need for the quick adoption of a premium cigar definition by the agency and the ultimate exemption
August 10th marks a major milestone in the implementation of FDA’s Deeming Rule. On this date, the warning label requirements for cigar and pipe tobacco packaging and advertising go into effect. Below are a few things retailers should know ahead of time. IPCPR plans to release additional briefs on aspects of the warning label
Earlier today, the US Food & Drug Administration (FDA) announced extensions to three advanced notice of proposed rulemaking (ANPRM) dockets currently underway. The extension covers the ANPRMs on nicotine reduction, flavors and premium cigars. This extension provides additional time for industry to present its case to the administration and submit comments to the FDA.